Third Harmonic Bio, Inc. (THRD)

Third Harmonic Bio Market Cap

Third Harmonic Bio has a market cap or net worth of $471.68 million as of April 19, 2024. Its market cap has increased by 159.31% in one year.

• Market Cap: 471.68M
• Enterprise Value: 199.80M
• 1-Year Change: 159.31%
• Ranking: #2991
• Category: Small-Cap
• Stock Price: $11.50

Market Cap Chart

Since the IPO on September 15, 2022, Third Harmonic Bio's market cap has decreased from $657.80M to $471.68M, a decrease of -28.29%. That is a compound annual growth rate of -18.86%.

Market Cap History

Date	Market Cap	% Change
Apr 18, 2024	465.40M	1.33%
Apr 17, 2024	459.30M	-2.67%
Apr 16, 2024	471.90M	-1.69%
Apr 15, 2024	480.00M	2.35%
Apr 12, 2024	469.00M	-3.85%
Apr 11, 2024	487.80M	0.35%
Apr 10, 2024	486.10M	7.76%
Apr 9, 2024	451.10M	1.64%
Apr 8, 2024	443.80M	1.88%
Apr 5, 2024	435.60M	5.93%
Apr 4, 2024	411.20M	8.47%
Apr 3, 2024	379.10M	6.55%
Apr 2, 2024	355.80M	-0.14%
Apr 1, 2024	356.30M	-7.29%
Mar 28, 2024	384.30M	-0.34%
Mar 27, 2024	385.60M	5.47%
Mar 26, 2024	365.60M	3.28%
Mar 25, 2024	354.00M	1.99%
Mar 22, 2024	347.10M	-7.83%
Mar 21, 2024	376.60M	0.75%
Mar 20, 2024	373.80M	1.66%
Mar 19, 2024	367.70M	0.88%
Mar 18, 2024	364.50M	-3.42%
Mar 15, 2024	377.40M	2.53%
Mar 14, 2024	368.10M	-5.40%

View and export this data all the way back to 2022. Sign Up Today.

Related Stocks

Company	Market Cap
C4 Therapeutics	477.12M
Shattuck Labs	474.75M
PetIQ	466.71M
Editas Medicine	457.75M
Theravance Biopharma	452.27M
Replimune Group	449.97M
Travere Therapeutics	448.22M
IGM Biosciences	446.78M